ロード中...
Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic
Glioblastoma, the most common primary malignant brain tumor, is among the most difficult cancers to treat. Despite the aggressive standard of care, including surgical removal followed by radiotherapy with concomitant and adjuvant chemotherapy, the often sudden onset, diffuse infiltrating nature and...
保存先:
| 出版年: | Drugs Future |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4317793/ https://ncbi.nlm.nih.gov/pubmed/25663738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1358/dof.2013.038.03.1933992 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|